Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats
Background: Fish oil, which is regarded as the primary source of omega-3 fatty acids, has been long studied for its potential as an antidiabetic therapy. However, its protective ability against insulin resistance and pancreatic islet alteration remains unclear and controversial. Aim: To investigate...
Published in: | Open Veterinary Journal |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Faculty of Veterinary Medicine, University of Tripoli
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85170550103&doi=10.5455%2fOVJ.2023.v13.i8.4&partnerID=40&md5=9accb65e45101da35678d001eee721bb |
id |
2-s2.0-85170550103 |
---|---|
spelling |
2-s2.0-85170550103 Titisari N.; Fauzi A.; Razak I.S.A.; Samsulrizal N.; Ahmad H. Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats 2023 Open Veterinary Journal 13 8 10.5455/OVJ.2023.v13.i8.4 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85170550103&doi=10.5455%2fOVJ.2023.v13.i8.4&partnerID=40&md5=9accb65e45101da35678d001eee721bb Background: Fish oil, which is regarded as the primary source of omega-3 fatty acids, has been long studied for its potential as an antidiabetic therapy. However, its protective ability against insulin resistance and pancreatic islet alteration remains unclear and controversial. Aim: To investigate the beneficial effects of fish oil consumption on the progression of insulin resistance and pancreatic islet dysfunction in a rat model of diabetes. Methods: Diabetic rats model (n = 30) were divided into five groups and received; 1) NS injection + NS oral (normal control); 2) NS injection + 3 g/kg fish oil (fish oil control); 3) streptozotocin (STZ) injection + NS oral [diabetes control (DC)]; 4) STZ injection + 1 g/kg fish oil (DFO1); and 5) STZ injection + 3 g/kg fish oil (DFO3). Fasting blood insulin was analyzed by commercial rat insulin enzyme-linked immunosorbent assay; meanwhile, the determination of insulin sensitivity was calculated by homeostatic model assessment of insulin resistance (HOMA-IR) and homeostatic model assessment of beta-cell function. A histological study was conducted on pancreas tissue using H and E staining. Results: Fish oil supplementation reduced hyperglycemia and ameliorated HOMA-IR in STZ-induced animal models indicating that fish oil supplementation improved insulin sensitivity. Furthermore, animals treated with fish oil at a dose of 3 g/kg (DFO3) showed an enhancement in pancreatic islets, which was displayed by less abnormal structures than DC animals. This could imply that the administration of fish oil, especially rich in bioactive omega-3 fatty acids effectively inhibits insulin resistance and restore islet of Langerhans alteration in rats injected with STZ. Conclusion: Thus, the current study suggested that fish oil supplementation could support the treatment of diabetes but should not be considered as an alternative therapy. © 2023, Faculty of Veterinary Medicine, University of Tripoli. All rights reserved. Faculty of Veterinary Medicine, University of Tripoli 22264485 English Article All Open Access; Gold Open Access |
author |
Titisari N.; Fauzi A.; Razak I.S.A.; Samsulrizal N.; Ahmad H. |
spellingShingle |
Titisari N.; Fauzi A.; Razak I.S.A.; Samsulrizal N.; Ahmad H. Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
author_facet |
Titisari N.; Fauzi A.; Razak I.S.A.; Samsulrizal N.; Ahmad H. |
author_sort |
Titisari N.; Fauzi A.; Razak I.S.A.; Samsulrizal N.; Ahmad H. |
title |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
title_short |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
title_full |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
title_fullStr |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
title_full_unstemmed |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
title_sort |
Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats |
publishDate |
2023 |
container_title |
Open Veterinary Journal |
container_volume |
13 |
container_issue |
8 |
doi_str_mv |
10.5455/OVJ.2023.v13.i8.4 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85170550103&doi=10.5455%2fOVJ.2023.v13.i8.4&partnerID=40&md5=9accb65e45101da35678d001eee721bb |
description |
Background: Fish oil, which is regarded as the primary source of omega-3 fatty acids, has been long studied for its potential as an antidiabetic therapy. However, its protective ability against insulin resistance and pancreatic islet alteration remains unclear and controversial. Aim: To investigate the beneficial effects of fish oil consumption on the progression of insulin resistance and pancreatic islet dysfunction in a rat model of diabetes. Methods: Diabetic rats model (n = 30) were divided into five groups and received; 1) NS injection + NS oral (normal control); 2) NS injection + 3 g/kg fish oil (fish oil control); 3) streptozotocin (STZ) injection + NS oral [diabetes control (DC)]; 4) STZ injection + 1 g/kg fish oil (DFO1); and 5) STZ injection + 3 g/kg fish oil (DFO3). Fasting blood insulin was analyzed by commercial rat insulin enzyme-linked immunosorbent assay; meanwhile, the determination of insulin sensitivity was calculated by homeostatic model assessment of insulin resistance (HOMA-IR) and homeostatic model assessment of beta-cell function. A histological study was conducted on pancreas tissue using H and E staining. Results: Fish oil supplementation reduced hyperglycemia and ameliorated HOMA-IR in STZ-induced animal models indicating that fish oil supplementation improved insulin sensitivity. Furthermore, animals treated with fish oil at a dose of 3 g/kg (DFO3) showed an enhancement in pancreatic islets, which was displayed by less abnormal structures than DC animals. This could imply that the administration of fish oil, especially rich in bioactive omega-3 fatty acids effectively inhibits insulin resistance and restore islet of Langerhans alteration in rats injected with STZ. Conclusion: Thus, the current study suggested that fish oil supplementation could support the treatment of diabetes but should not be considered as an alternative therapy. © 2023, Faculty of Veterinary Medicine, University of Tripoli. All rights reserved. |
publisher |
Faculty of Veterinary Medicine, University of Tripoli |
issn |
22264485 |
language |
English |
format |
Article |
accesstype |
All Open Access; Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1809678020489773056 |